Simris Group names Dr. Tiffany J. Vora strategic advisor

PUBT · 2d ago
Simris Group names Dr. Tiffany J. Vora strategic advisor
  • Simris Group named biotechnology scientist and entrepreneur Dr. Tiffany J. Vora as strategic adviser.
  • Mandate centers on expanding engagement with the US biotechnology, financing, and innovation ecosystem.
  • Role includes advising Simris Biologics CEO Andreas Pahl on advancing the group’s antibody-drug conjugate platform.
  • Vora previously worked in drug target validation at Bristol-Myers Squibb; she later founded and advised science-focused ventures.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simris Group AB published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.